C.R. BARD, INC. (BASD) -3006260740 POWERPORT CLEARVUE ISP IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
|
Back to Search Results |
|
Catalog Number 5608062 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Fever (1858); Unspecified Infection (1930)
|
Event Date 12/02/2022 |
Event Type
Injury
|
Event Description
|
It was reported through the litigation process that sometime post a port placement, the patient allegedly experienced infection.The current status of the patent is unknown.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a manufacturing review was not requested as the lot number reported as unknown.Investigation summary: the physical device was not returned for evaluation.No medical record was provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.The definitive root cause could not be determined based upon available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
|
|
Event Description
|
It was reported through the litigation process that one month and nineteen days post a port placement, the patient allegedly developed fever and bacteremia.The device was removed from the patient.The current status of the patent is unknown.
|
|
Manufacturer Narrative
|
Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately one month, two weeks later and four days later, the patient was hospitalized for fever and was found to be neutropenic.The patient was initiated on intravenous antibiotics.The blood cultures return positive for staph lugdunensis.Two days later port removal under fluoroscopic guidance was performed due to port infection.An incision was made over the existing scar corresponding to the implanted port in the right anterior chest.The port was freed from the underlying subcutaneous tissue using blunt dissection.The port was delivered through the incision and removed intact under fluoroscopic guidance.The port pocket was then irrigated.The port removal was successful.The removed port tip grew staph as well.Echo was negative for valve vegetations.The patient will be continuing antibiotics.Therefore, it can be confirmed that the patient experienced bacteremia.However, the relationship to the port is unknown.Furthermore, the clinical condition alleged in the complaint cannot be confirmed.The definitive root cause could not be determined based upon available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.The information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Search Alerts/Recalls
|
|
|